Oruka Therapeutics (ORKA) SVP trades 9,999 shares under Rule 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Oruka Therapeutics, Inc. Senior Vice President, Finance Agarwal Arjun reported open-market sales of common stock and exercises of employee stock options on July 13, 2026. He sold a total of 9,999 shares of common stock in multiple open-market transactions at weighted-average prices between $82.49 and $85.69 per share, pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026. On the same date, he exercised employee stock options to acquire 9,999 shares of common stock at exercise prices of $34.39 and $12.50 per share.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 9,999 shares ($846,180)
Net Sell
8 txns
Insider
Agarwal Arjun
Role
Senior Vice President, Finance
Sold
9,999 shs ($846K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 8,541 | $0.00 | -- |
| Exercise | Employee Stock Option (right to buy) | 1,458 | $0.00 | -- |
| Exercise | Common Stock | 8,541 | $12.50 | $107K |
| Exercise | Common Stock | 1,458 | $34.39 | $50K |
| Sale | Common Stock | 300 | $83.0665 | $25K |
| Sale | Common Stock | 3,743 | $84.2557 | $315K |
| Sale | Common Stock | 5,656 | $84.9012 | $480K |
| Sale | Common Stock | 300 | $85.6333 | $26K |
Holdings After Transaction:
Employee Stock Option (right to buy) — 101,459 shares (Direct);
Common Stock — 23,853 shares (Direct)
Footnotes (1)
- These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.49 to $83.37, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.54 to $84.53, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.54 to $85.50, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.56 to $85.69, inclusive. The option vests as to 1/48 of the underlying shares monthly from January 1, 2025. The option vests as to 1/48 of the underlying shares monthly from January 1, 2026.
Key Figures
Common shares sold: 9,999 shares
Sale price range: $82.49–$85.69 per share
Options exercised (shares): 9,999 shares
+3 more
6 metrics
Common shares sold
9,999 shares
Total open-market sales of common stock on July 13, 2026
Sale price range
$82.49–$85.69 per share
Price ranges for the multiple open-market sales on July 13, 2026
Options exercised (shares)
9,999 shares
Total shares acquired through employee stock option exercises on July 13, 2026
Option exercise price 1
$34.39 per share
Exercise price for a 1,458-share employee stock option exercised
Option exercise price 2
$12.50 per share
Exercise price for an 8,541-share employee stock option exercised
Option expiration dates
2036-01-22; 2035-01-21
Expiration dates for the employee stock options involved in the exercises
Key Terms
Rule 10b5-1 trading plan, weighted average price, Employee Stock Option (right to buy), derivative security
4 terms
Rule 10b5-1 trading plan regulatory
"These sales were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Employee Stock Option (right to buy) financial
"security_title": "Employee Stock Option (right to buy)""
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What insider stock transactions involving ORKA did Agarwal Arjun report on July 13, 2026?
Agarwal Arjun reported open-market sales and stock option exercises in Oruka Therapeutics (ORKA) on July 13, 2026. He both sold common shares and exercised employee stock options for additional shares on the same date.
What stock options did Agarwal Arjun exercise in his ORKA transactions on July 13, 2026?
He exercised employee stock options to acquire 9,999 shares of Oruka Therapeutics common stock. These included 1,458 shares at an exercise price of $34.39 and 8,541 shares at an exercise price of $12.50 per share.
Were Agarwal Arjun’s ORKA stock sales made under a Rule 10b5-1 trading plan?
Yes. The sales were effected pursuant to a Rule 10b5-1 trading plan that Agarwal Arjun entered into on February 11, 2026. Such plans are designed to pre-schedule trades according to predetermined instructions.